This tool will take you through current, open clinical trials in the UK and help you to understand which trials may be suitable for you. With any clinical trial you will need to be referred by your Health Care Specialist, always seek advice when considering clinical trials.

Further information can be found on our website under Clinical Trials and Novel Drugs or if you would like to speak to someone please call the Myeloma UK infoline on: 0800 980 3332

The Myeloma Trial Finder is intended only to provide information about clinical trials currently available in the UK. Trials included on Myeloma Trial Finder are not necessarily endorsed by Myeloma UK. Clinical trials involve inherent risks and any decision to participate, or not participate, in a clinical trial should be taken only after a careful assessment of the risks involved in it. Please speak to your haematologist if you are interested in taking part in a clinical trial. To the fullest extent permitted by law Myeloma UK excludes all liability howsoever arising (including negligence) as a consequence of, or in connection with, the use of information provided by Myeloma Trial Finder

There are currently 30 open trials. In 129 locations

What is a Clinical Trial?

Step 2: Choose a Trial

There are currently 30 open trials

Step 3: View Details

Trial Title:

Exercise in transplant eligible myeloma patients (PERCEPT)


Exercise programme

Myeloma stage:

Trial phase:



The aim of this study is to assess the feasibility of a physiotherapist-led exercise programme before and during stem cell transplant treatment in people with myeloma.



University College Hospital, London

Who can enter the study?

Who can enter the study?:

Patients with myeloma who are having high dose therapy and stem cell transplant.

What's involved?

What's involved?:

Participants are randomly assigned to two groups:

  • the exercise group – where members will participate in an exercise programme in addition to usual care
  •  the control group – where members will receive usual care

The exercise group undertake individually tailored aerobic and resistance exercise with behaviour change support during three phases of their treatment.

In phase 1, for 6-8 weeks before they come into hospital for their stem cell transplant they are asked to exercise three times per week. They are asked to take part in one session a week with a physiotherapist in a gym and complete two other sessions at home.

In phase 2, during their hospital stay, immediately after their stem cell transplant, the exercise participants are offered supervised exercise sessions with a physiotherapist three times per week.

In phase 3, for 3 months after they leave hospital the participants are asked to continue exercising at home three times per week. They receive weekly phone or Skype support from a physiotherapist to promote and support continuation or return to independent exercise in the post-transplant period.

Clinical Information

Clinical Information
(for Medical Professionals):

The primary objective of this study is to evaluate the feasibility of delivering an exercise and behaviour change intervention prior to and during the usual high dose therapy and stem cell transplant treatment pathway in people with myeloma. Secondary objectives are to investigation of the possible effect of the intervention on a range of measures including fatigue, quality of life, physical activity and functional capacity.

For more information, click here.

Do you want to talk to someone? Call our myeloma Infoline